×
About 2,400 results

ALLMedicine™ Chronic Urticaria Center

Research & Reviews  543 results

Bridging knowledge gaps in paediatric chronic urticaria through a video-based education...
https://doi.org/10.1093/ced/llac054
Clinical and Experimental Dermatology; Karim J, Gabrielli S et. al.

Feb 3rd, 2023 - There is a lack of patient educational resources about chronic urticaria (CU). To develop and test the effectiveness of an education tool to help paediatric patients and their families better understand CU and its management. From July 2020 to May...

Current and future management of chronic spontaneous urticaria and chronic inducible ur...
https://doi.org/10.2500/aap.2023.44.220093
Allergy and Asthma Proceedings; Do TT, Canty EA et. al.

Feb 1st, 2023 - Background: Chronic urticaria (CU), characterized by ≥6 weeks of intense pruritus, remains a debilitating condition for patients. New and safe treatments are needed to manage CU recalcitrant to standard therapy. Objective: A review of the current ...

Clinical Outcomes, Patient-Reported Outcomes, and Economic Burden for Thai People Livin...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858793
PloS One; Chuamanochan M, Nochaiwong S

Jan 21st, 2023 - Few prospective longitudinal studies have been conducted in Thailand to account for the long-term response to chronic urticaria (CU) treatment, clinical outcomes, and patient-reported outcomes (PROs) among people living with CU based on routine pr...

Normocomplementemic urticarial vasculitis secondary to Lyme disease: A rare association...
https://doi.org/10.1177/14782715221144167
The Journal of the Royal College of Physicians of Edinburgh; Teles C, Gaspar E et. al.

Dec 16th, 2022 - Urticarial vasculitis (UV) is a rare entity characterised by long-lasting recurrent episodes of urticarial lesions. Although frequently idiopathic, UV has been associated with multiple diseases, including infections. We present a case of Lyme dise...

An update on anaphylaxis and urticaria.
https://doi.org/10.1016/j.jaci.2022.10.014
The Journal of Allergy and Clinical Immunology; Worm M, Vieths S et. al.

Dec 9th, 2022 - Notable scientific developments have taken place in the field of anaphylaxis and urticaria in recent years; they are highlighted in this review. Case-control studies, genome-wide association studies, and large omics analyses have promoted further ...

see more →

Drugs  269 results see all →

Clinicaltrials.gov  65 results

COrticosteroids in acUte uRticAria in emerGency dEpartment
https://clinicaltrials.gov/ct2/show/NCT03545464

Dec 9th, 2022 - Acute urticaria (hives) is a common skin disease. The prevalence of acute urticaria in life is about 15 to 20% in the general population. It is responsible for a frequent use of emergency departments (ED). The usual treatment is based on early adm...

Mepolizumab for the Treatment of Chronic Spontaneous Urticaria
https://clinicaltrials.gov/ct2/show/NCT03494881

Dec 2nd, 2022 - This is an open-label, single arm exploratory study of mepolizumab in the treatment of CSU. The primary endpoint will be the mean reduction in the seven day urticaria activity score (UAS7) before and after 10 weeks of treatment with mepolizumab. S...

The Association Between Human Microbiome and Vitamin D in Chronic Urticaria
https://clinicaltrials.gov/ct2/show/NCT05497596

Sep 1st, 2022 - Urticaria is a chronic allergic inflammatory disorder. Genetic and environmental factors, such as exposure to allergens and microbes, have a detrimental role in the development of chronic urticaria. Vitamin D also has an important role in urticari...

Positive Psychotherapy-Based Counseling (PPT)
https://clinicaltrials.gov/ct2/show/NCT05513079

Aug 26th, 2022 - Chronic urticaria is a condition that impairs the patient's quality of life, interferes with routine daily activities, and is often associated with anxiety. It constitutes a significant burden associated with psychiatric comorbidities such as Fund...

The Role of the Coagulation Pathways in Recurrent Angioedema
https://clinicaltrials.gov/ct2/show/NCT02892682

Aug 25th, 2022 - Previous studies reported infraclinical modifications of the homeostasis in chronic urticaria, recurrent idiopathic angioedema and hereditary angioedema. This study aim to compare groups with isolated wheals, isolated angioedema, combination of bo...

see more →

News  82 results

Doctors Can Combat Urticaria Misinformation With Empathy and Facts
https://www.medscape.com/viewarticle/984393

Nov 21st, 2022 - Patients suffering from chronic urticaria can easily find bogus causes and treatments online, and providers need to refute the falsehoods with facts, a research letter suggests. "Chronic urticaria can have a major psychological impact, leaving pat...

Disgust sensitivity and IBS: Is there a link?
https://www.mdedge.com/clinicianreviews/article/258898/ibd-intestinal-disorders/disgust-sensitivity-and-ibs-there-link

Oct 24th, 2022 - Key clinical point: Disgust sensitivity may act as a potential trigger or predisposition factor for irritable bowel syndrome (IBS), particularly in women. Major finding: Disgust sensitivity was positively correlated with IBS (correlation coefficie.

Chronic Urticaria During Pregnancy: Study Analyzes Outcomes, Treatments
https://www.medscape.com/viewarticle/982304

Oct 12th, 2022 - Most patients with chronic urticaria (CU) used treatment during pregnancy, especially with second-generation antihistamines, which appear to be safe regardless of the trimester. In addition, the rates of preterm births and medical problems of newb...

How do patients with chronic urticaria fare during pregnancy?
https://www.mdedge.com/dermatology/article/258561/medical-dermatology/how-do-patients-chronic-urticaria-fare-during
Doug Brunk

Oct 11th, 2022 - Most patients with chronic urticaria (CU) used treatment during pregnancy, especially with second-generation antihistamines, which appear to be safe regardless of the trimester. In addition, the rates of preterm births and medical problems of newb.

Targeted Anti-IgE Therapy Found Safe and Effective for Chronic Urticaria
https://www.medscape.com/viewarticle/980846

Sep 15th, 2022 - MILAN – The therapeutic value of inhibiting the activity of IgE in patients with chronic spontaneous urticaria (CSU) was reinforced by two large phase 3 trials with ligelizumab, a drug characterized as a new generation anti-IgE monoclonal antibody...

see more →

Patient Education  1 results see all →